Relapsed Non Hodgkin Lymphoma Recruiting Phase 2 Trials for Antilymphocyte immunoglobulin (horse) (DB09312)

IndicationStatusPhase
DBCOND0062858 (Relapsed Non Hodgkin Lymphoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01811368Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin LymphomaTreatment